Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]
Titel:
Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]
Auteur:
Lai, Fangfang Ji, Ming Huang, Lei Wang, Yunchen Xue, Nina Du, Tingting Dong, Kai Yao, Xiaoqing Jin, Jing Feng, Zhiqiang Chen, Xiaoguang
Verschenen in:
Acta pharmaceutica sinica B
Paginering:
Jaargang 13 () nr. 7 pagina's 3178-3179
Jaar:
2023
Inhoud:
Uitgever:
Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences